University of Kansas Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Kansas Medical Center sits in the top decile of US sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count).
University of Kansas Medical Center: 408 sponsored US clinical trials, 93 recruiting.
University of Kansas Medical Center sponsors 408 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 252 completed. 28 of these trials are in Phase 3-4 (later-stage) and 85 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Smoking Cessation, with 9 trials.
Top-decile sponsor footprint
University of Kansas Medical Center ranks in the top decile of sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
252 of 275 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
408 total, page 2 of 9
AvoCog - the Effect of Daily Avocado Intake on Cognitive Function in Older Adults
NCT06137339
Guided Episodic Future Thinking to Increase Physical Activity Adherence and Promote Healthy Brain Aging
NCT06123182
To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors
NCT06247553
NLit and Outcomes in HNC Survivor-Caregiver Dyads
NCT07021885
Hyperpolarized 129Xe MRI Lung Health Cohort
NCT05766384
ESPBs vs TAPs for Satisfactory Analgesia Following DIEP Surgery
NCT06091241
Opioid-Free Pain Treatment in Trauma Patients
NCT06078371
Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL
NCT06050850
Changes in Resting Metabolic Rate Following Orthopedic Surgery
NCT06107959
Switching to E-cigarettes in Smokers Not Interested in Quitting
NCT05703672
More and Less Social Comprehension
NCT06116552
Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes
NCT05869812
Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study
NCT06017141
Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment
NCT05732272
vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC
NCT05727787
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
NCT05645380
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
NCT06425848
Transduction of Sympathetic Neural Activity in Human Obesity Without Hypertension
NCT06626113
Ultrasound Guided Radiofrequency Ablation of the Occipital Nerve
NCT06583122
Quantitative Pulmonary Imaging Registry & Biorepository
NCT05530408
Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC
NCT04467723
Reversing Glucose and Lipid-mediated Vascular Dysfunction
NCT04832009
Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer
NCT04992780
Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
NCT04530383
LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
NCT04979156
Interstitial Lung Disease Research Unit Biobank
NCT05392881
Mitigating the Pro-inflammatory Phenotype of Obesity
NCT04934228
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
NCT04715022
Post COVID-19 Biorepository
NCT04885504
Evaluation of Multi-Tined Expandable Electrode (MEE) Efficacy and Safety in Treatment of Lumbar Facet Arthropathy by Radiofrequency Neurotomies Compared to Conservative Medical Management.
NCT04730700
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
NCT04635891
Pulmonary Hypertension Biorepository and Registry
NCT04808596
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
NCT03533816
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
NCT03802851
User-friendliness of a Portable Driving Simulator
NCT03969927
Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization
NCT03794466
Head Positioning After Retina Detachment Repair
NCT03714503
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
NCT03854344
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
NCT03458832
Exosomes in Rectal Cancer
NCT03874559
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
NCT03413982
Early PKD Observational Cohort Study
NCT02936791
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
NCT02302742
Motor-Cognitive Training for Motoric Cognitive Risk Syndrome
NCT07223905
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
NCT06485089
Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma
NCT06178588
Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time
NCT06153108
Carbohydrate Ingestion Prior to Surgery (CIPS)
NCT06057532
iAmHealthy Parents First: A Televideo Parent and Child Obesity Program for Rural Families
NCT05612971
Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)
NCT05915351
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 40 |
| Phase 2 | 45 |
| Phase 3 | 9 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Kansas Medical Center pipeline
93 recruiting of 408 indexed (23% open); 252 completed (62%).
Phase mix: 28 late (III/IV) vs 85 early (I/II) (early-phase heavy).
Top condition: Smoking Cessation (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Kansas Medical Center: open-pipeline peers nationwide
Peers matched on 408 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
University of Kansas Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 408 trials (± recruiting share)
- Takeda · 408 trials · 12% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
- University of Nebraska · 407 trials · 13% recruiting
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Veterans Medical Research Foundation · 23% recruiting · 35 trials
- University of Delaware · 23% recruiting · 106 trials
- University of Texas at Austin · 23% recruiting · 257 trials
- Ohio State University Comprehensive Cancer Center · 23% recruiting · 341 trials
Related
What to do with this University of Kansas Medical Center page
408 registered trials is a research-attention snapshot, not an endorsement of University of Kansas Medical Center or any single study.
- 93 of University of Kansas Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Smoking Cessation is the condition University of Kansas Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Smoking Cessation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Kansas Medical Center pipeline card: 408 registered trials from official public datasets.Report a data error.